Octahydrobenzo(6,7)cyclohept(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
申请人:Merck & Co., Inc.
公开号:EP0080116A2
公开(公告)日:1983-06-01
4-Substituted-2,3,4,4a,5,6,7,11b-octahydrobenzo[6,7]-cyclohept[1,2-b]-1,4-oxazines are prepared from the corresponding 6-(substituted amino)-6,7,8,9-tetrahydro-5H-benzocycloheptene-5-ol. The trans-4-substituted-2,3,4,4a,5,6,7, 11b-octahydrobenzo[6,7]cyclohept[1,2-b]-1,4-oxazines have a-adrenergic agonist and tetrabenazine antagonist activity.
反式-4-取代-2,3,4,4a,5,6,7,11b-八氢苯并[6,7]环庚烷[1,2-b]-1,4-噁嗪由相应的 6-(取代氨基)-6,7,8,9-四氢-5H-苯并环庚烯-5-醇制备而成。 反式-4-取代-2,3,4,4a,5,6,7,11b-八氢苯并[6,7]环庚烷[1,2-b]-1,4-噁嗪具有肾上腺素能激动剂和四苯嗪拮抗剂活性。